Masaru Matsuda, See Remarks at Arcutis Biotherapeutics, Inc. (ARQT), sold 14,373 shares at $24.71 ($355K) on 2025-11-03, disclosed to the SEC on 2025-11-05.
Scheduled sale ($355k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.71 | 7,165 | $177K | 49.8% |
| 2 | $24.71 | 7,165 | $177K | 49.8% |
| 3 | $25.40 | 43 | $1K | 0.3% |
| Total | $24.71 avg | 14,373 | $355K | 100% |
| Filing → |
| ARQT | SELL | 2026-08-05 | $32K | — | Filing → |
| ARQT | SELL | 2026-05-06 | $192K | — | Filing → |
| ARQT | SELL | 2026-03-03 | $314K | — | Filing → |